Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

GSK 1,363.50 +18.00 (1.34%)
price chart
GlaxoSmithKline settles healthcare fraud case for $3 billion
WASHINGTON GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S.
GlaxoSmithKline to pay $3billion fine after pleading guilty to healthcare ...  Daily Mail
Glaxo Agrees to Pay $3 Billion in Fraud Settlement  New York Times
GSK clinches deal to buy Human Genome for $3 billion
LONDON/BOSTON GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile pursuit of the U.S.
Glaxo to Pay $3 Billion for Human Genome  Bloomberg
DOW JONES, A NEWS CORP COMPANY
Drug maker GlaxoSmithKline PLC agreed to plead guilty to criminal charges of illegally marketing drugs and withholding safety data from U.S.
GlaxoSmithKline to pay $3 billion in fines, the largest health care fraud ...  New York Daily News
Glaxo Pleads Guilty, Fined $1 Billion in Drug-Marketing Case  Bloomberg
3 U.K. Stocks With U.S.-Style Dividends And No Tax Withholding For A Dividend ...
... British multinationals in three diverse sectors that pay American-style quarterly dividends that remain stable with consistent growth from year to year: Royal Dutch Shell PLC Class B (RDS.
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
Glaxo Tries to Shake Marketing Questions
GlaxoSmithKline PLC's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair—the company's biggest moneymaker and one of the top-selling drugs in the world.
Glaxo Executives Cited in Case Now Lead Sanofi, Actelion
Two senior executives at GlaxoSmithKline Plc singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies.
Big Pharma is in big trouble � or should be
Something is definitely wrong in their management and monitoring systems. GSK are not able to say that the activities for which they were fined were anything other than deliberate.
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test
An experimental treatment for HIV developed by GlaxoSmithKline Plc, Pfizer Inc. and Shionogi & Co. reduced the virus in more people than Gilead Sciences Inc.'s Atripla, suggesting it may supplant the world's best-selling AIDS medicine as the preferred ...
What is a defensive stock?
Why I'd Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC · Things Could Get Even Worse For HSBC Holdings plc, Royal Bank of Scotland Group plc & Standard Chartered PLC · Winter Portfolios mauled in January · Share of the week: Tullow ...